Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
Titel:
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
Auteur:
Della Porta, Matteo Giovanni Garcia-Manero, Guillermo Santini, Valeria Zeidan, Amer M Komrokji, Rami S Shortt, Jake Valcárcel, David Jonasova, Anna Dimicoli-Salazar, Sophie Tiong, Ing Soo Lin, Chien-Chin Li, Jiahui Zhang, Jennie Pilot, Richard Kreitz, Sandra Pozharskaya, Veronika Keeperman, Karen L Rose, Shelonitda Prebet, Thomas Lai, Yinzhi Degulys, Andrius Paolini, Stefania Cluzeau, Thomas Fenaux, Pierre Platzbecker, Uwe